SNDX FY 2016 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+94.6% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$44M-3587.4% margin

Net Income

-$44M-3645.2% margin

EPS (Diluted)

$-3.04

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$109M

Total Liabilities

$25M

Stockholders' Equity

$84M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$627,000	+94.6%
Gross Profit	$1M	$627,000	+94.6%
Operating Income	-$44M	-$21M	-113.4%
Net Income	-$44M	-$24M	-84.4%